Search

Search Constraints

You searched for: Author/Creator Brandes, Alba Ariela

Search Results

1. A molecular signature associated with prolonged survival in glioblastoma patients treated with regorafenib. Issue 2 (14th July 2020)

2. Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study. Issue 6 (June 2021)

3. Association between socioeconomic status and survival in glioblastoma: An Italian single-centre prospective observational study. (March 2021)

5. Distinct MRI pattern of "pseudoresponse" in recurrent glioblastoma multiforme treated with regorafenib: Case report and literature review. Issue 8 (21st August 2021)

8. Expertise is crucial to prolong survival in average risk medulloblastoma: long-term results of a retrospective study. Issue 4 (August 2022)